NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled
NCT02419495 2025-06-04Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Terminated221 enrolled
NCT05769959 2024-07-09Study of RO7515629 in Participants With HLA-G Positive Solid TumorsHoffmann-La RochePhase 1 Terminated3 enrolled
NCT03621982 2024-06-13Study of ADCT-301 in Patients With Selected Advanced Solid TumorsADC Therapeutics S.A.Phase 1 Terminated78 enrolled 39 charts
NCT03311334 2024-04-18A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsSumitomo Pharma America, Inc.Phase 1/2 Terminated47 enrolled 11 charts
NCT00904514 2018-10-05Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialNational Institutes of Health Clinical Center (CC)Terminated241 enrolled